info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

New-Born Screening Market Research Report Information, By Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays, Pulse Oximetry, and Antigen Typing), By Test Type (Dry Blood Spot Test, Hearing Screening Test, and Critical Congenital Heart Diseases (CCHD) Test), By Product (Reagents, Assay Kits, and Instruments), By End-User (Hospitals, Maternity, and Specialty Clinic, and Diagnostic Centers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecas


ID: MRFR/MED/5099-CR | 141 Pages | Author: Rahul Gotadki| October 2019

Market Segmentation


New-Born Screening Technology Outlook (USD Billion, 2018-2032)




  • Tandem mass spectrometry




  • Immunoassays and enzymatic assays




  • Hearing screening technology




  • DNA assays and pulse oximetry




  • Antigen typing




New-Born Screening, Test type Outlook (USD Billion, 2018-2032)




  • Dry blood spot test




  • Hearing screening test




  • Critical congenital heart diseases (CCHD) test




New-Born Screening Product Outlook (USD Billion, 2018-2032)




  • Reagents




  • Assay kits




  • Instruments




New-Born Screening End-user Outlook (USD Billion, 2018-2032)




  • Hospitals




  • Maternity and specialty clinic




  • Diagnostic centers




New-Born Screening Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • North America New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • North America New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • North America New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • US Outlook (USD Billion, 2018-2032)




    • US New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • US New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • US New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • US New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • CANADA New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • CANADA New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • CANADA New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Europe New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Europe New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Europe New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Germany New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Germany New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Germany New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • France Outlook (USD Billion, 2018-2032)




    • France New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • France New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • France New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • France New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • UK Outlook (USD Billion, 2018-2032)




    • UK New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • UK New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • UK New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • UK New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • ITALY New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • ITALY New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • ITALY New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Spain New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Spain New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Spain New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • REST OF EUROPE New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • REST OF EUROPE New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • REST OF EUROPE New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Asia-Pacific New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Asia-Pacific New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Asia-Pacific New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • China Outlook (USD Billion, 2018-2032)




    • China New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • China New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • China New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • China New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Japan New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Japan New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Japan New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • India Outlook (USD Billion, 2018-2032)




    • India New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • India New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • India New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • India New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Australia New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Australia New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Australia New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Rest of Asia-Pacific New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Rest of Asia-Pacific New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Rest of Asia-Pacific New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Rest of the World New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Rest of the World New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Rest of the World New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Middle East New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Middle East New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Middle East New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Africa New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Africa New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Africa New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America New-Born Screening by Technology




      • Tandem mass spectrometry




      • Immunoassays and enzymatic assays




      • Hearing screening technology




      • DNA assays and pulse oximetry




      • Antigen typing






    • Latin America New-Born Screening by Test type




      • Dry blood spot test




      • Hearing screening test




      • Critical congenital heart diseases (CCHD) test






    • Latin America New-Born Screening by Product




      • Reagents




      • Assay kits




      • Instruments






    • Latin America New-Born Screening by End-user




      • Hospitals




      • Maternity and specialty clinic




      • Diagnostic centers







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 20

3.2 Scope of the Study 20

3.3 Assumptions & Limitations 20

3.3.1 Assumptions 20

3.3.2 Limitations 20

3.4 Market Structure 21

4 Research Methodology

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 26

4.5 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 29

5.2.1 Rising Prevalence of Diseases in New-Born Children 29

5.2.2 Government Support and New-Born Screening Programs 29

5.2.3 Increasing Neonatal Population 29

5.2.4 Technological Advancements 30

5.3 Restraints 30

5.3.1 Unreliability of Few New-Born Screening Tests 30

5.3.2 Lack of Proper Healthcare Infrastructure and Trained Professionals 30

5.4 Opportunities 31

5.4.1 Screening of Genetic Diseases 31

5.5 Challenges 31

5.5.1 Heavy Cost of Automation Technology 31

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 33

6.1.1 Bargaining Power of Suppliers 33

6.1.2 Bargaining Power of Buyers 33

6.1.3 Threat of New Entrants 34

6.1.4 Threat of Substitutes 34

6.1.5 Intense Rivalry 34

6.2 Supply Chain Analysis 35

6.2.1 R&D and Designing 35

6.2.2 Manufacturing 35

6.2.3 Distribution & Sales 35

6.2.4 Post-Sales Monitoring 35

7 New-Born Screening Market, By Product

7.1 Introduction 37

7.2 Reagents and Assay Kits 38

7.3 Instruments 39

8 New-Born Screening Market, By Technology

8.1 Introduction 42

8.2 Tandem Mass Spectrometry 43

8.3 Immunoassays and Enzymatic Assays 44

8.4 Hearing Screening Technology 45

8.5 DNA Assays 46

8.6 Pulse Oximetry 47

9 New-Born Screening Market, By Test Type

9.1 Introduction 49

9.2 Dry Blood Spot Test 50

9.3 Hearing Screening Test 51

9.4 Critical Congenital Heart Disease (CCHD) Test 52

10 New-Born Screening Market, By End-User

10.1 Introduction 54

10.2 Hospitals 55

10.3 Maternity and Specialty Clinics 56

10.4 Diagnostic Centers 56

11 Global New-Born screening Market, By Region

11.1 Introduction 58

11.2 Americas 59

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1 North America 62

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1.1 U.S. 64

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.1.2 Canada 66

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.2.2 South America 68

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3 Europe 70

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1 Western Europe 72

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.1 Germany 74

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.2 France 76

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.3 UK 78

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.4 Italy 80

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.5 Spain 82

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.1.6 Rest of Western Europe 84

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.3.2 Eastern Europe 86

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4 Asia-Pacific 88

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.1 Japan 91

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.2 China 93

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.3 India 95

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.4 Australia 97

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.5 Republic of Korea 99

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.4.6 Rest of Asia-Pacific 101

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5 Middle East and Africa 103

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5.1 Middle East 105

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

11.5.2 Africa 107

New-Born Screening Market, By Product

New-Born Screening Market, By Technology

New-Born Screening Market, By Test Type

New-Born Screening Market, By End-User

12 Competitive Landscape

12.1 Company Market Share Analysis 110

12.1.1 Introduction 110

13 Company Profiles

13.1 SCIEX 113

13.1.1 Company Overview 113

13.1.2 Financial Overview 113

13.1.3 Products/Services Offered 114

13.1.4 SWOT Analysis 114

13.1.5 Key Developments 114

13.1.6 Key Strategy 114

13.2 PerkinElmer Inc. 115

13.2.1 Company Overview 115

13.2.2 Financial Overview 115

13.2.3 Products/Services Offered 116

13.2.4 SWOT Analysis 116

13.2.5 Key Developments 116

13.2.6 Key strategy 117

13.3 WATERS 118

13.3.1 Company Overview 118

13.3.2 Financial Overview 118

13.3.3 Products/Services Offered 119

13.3.4 SWOT Analysis 119

13.3.5 Key Developments 119

13.3.6 Key strategy 119

13.4 Natus Medical Incorporated 120

13.4.1 Company Overview 120

13.4.2 Financial Overview 120

13.4.3 Products/Services Offered 121

13.4.4 SWOT Analysis 121

13.4.5 Key Developments 121

13.4.6 Key Strategy 121

13.5 Masimo Corporation 122

13.5.1 Company Overview 122

13.5.2 Financial Overview 122

13.5.3 Products/Services Offered 123

13.5.4 SWOT Analysis 123

13.5.5 Key Developments 123

13.5.6 Key Strategy 123

13.6 Agilent Technologies Inc. 124

13.6.1 Company Overview 124

13.6.2 Financial Overview 124

13.6.3 Products/Services Offered 125

13.6.4 SWOT Analysis 125

13.6.5 Key Development 125

13.6.6 Key Strategy 125

13.7 Bio-Rad Laboratories, Inc. 126

13.7.1 Company Overview 126

13.7.2 Financial Overview 126

13.7.3 Products/Services Offered 127

13.7.4 SWOT Analysis 127

13.7.5 Key Development 127

13.7.6 Key Strategy 127

13.8 Medtronic 128

13.8.1 Company Overview 128

13.8.2 Financial Overview 128

13.8.3 Products/Services Offered 129

13.8.4 SWOT Analysis 129

13.8.5 Key Development 129

13.8.6 Key Strategy 129

13.9 GENERAL ELECTRIC COMPANY 130

13.9.1 Company Overview 130

13.9.2 Financial Overview 130

13.9.3 Products/Services Offered 131

13.9.4 SWOT Analysis 131

13.9.5 Key Development 131

13.9.6 Key Strategy 131

13.10 Trivitron Healthcare 132

13.10.1 Financial Overview 132

13.10.2 Products/Services Offered 132

13.10.3 SWOT Analysis 133

13.10.4 Key Development 133

13.10.5 Key Strategy 133

13.11 ZenTech SA 134

13.11.1 Company Overview 134

13.11.2 Financial Overview 134

13.11.3 Products/Services Offered 134

13.11.4 SWOT Analysis 135

13.11.5 Key Development 135

13.11.6 Key Strategy 135

13.12 Thermo Fisher Scientific Inc. 136

13.12.1 Company Overview 136

13.12.2 Financial Overview 136

13.12.3 Products/Services Offered 137

13.12.4 SWOT Analysis 137

13.12.5 Key Development 137

13.12.6 Key Strategy 137

14 Appendix

14.1 Discussion Blue Print 139

15 List of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 PRIMARY INTERVIEWS 23

TABLE 3 GLOBAL NEW-BORN SCREENING MARKET BY PRODUCT, 2020-2027 (USD MILLION) 37

TABLE 4 GLOBAL NEW-BORN SCREENING MARKET FOR REAGENTS AND ASSAY BY REGION, 2020-2027 (USD MILLION) 38

TABLE 5 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY REGION, 2020-2027 (USD MILLION) 39

TABLE 6 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY TYPE, 2020-2027 (USD MILLION) 40

TABLE 7 GLOBAL NEW-BORN SCREENING MARKET BY TECHNOLOGY, 2020-2027 (USD MILLION) 43

TABLE 8 GLOBAL NEW-BORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY BY REGION, 2020-2027 (USD MILLION) 43

TABLE 9 GLOBAL NEW-BORN SCREENING MARKET FOR IMMUNOASSAY AND ENZYMATIC ASSAYS BY REGION,

2020-2027 (USD MILLION) 44

TABLE 10 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGY BY REGION, 2020-2027 (USD MILLION) 45

TABLE 11 GLOBAL NEW-BORN SCREENING MARKET FOR DNA ASSAY BY REGION, 2020-2027 (USD MILLION) 46

TABLE 12 GLOBAL NEW-BORN SCREENING MARKET FOR PULSE OXIMETRY BY REGION, 2020-2027 (USD MILLION) 47

TABLE 13 GLOBAL NEW-BORN SCREENING MARKET BY TEST TYPE, 2020-2027 (USD MILLION) 50

TABLE 14 GLOBAL NEW-BORN SCREENING MARKET FOR DRY BLOOD SPOT BY REGION, 2020-2027 (USD MILLION) 50

TABLE 15 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TEST BY REGION, 2020-2027 (USD MILLION) 51

TABLE 16 GLOBAL NEW-BORN SCREENING MARKET FOR CRITICAL CONGENITAL HEART DISEASE TEST BY REGION,

2020-2027 (USD MILLION) 52

TABLE 17 GLOBAL NEW-BORN SCREENING MARKET BY END-USER, 2020-2027 (USD MILLION) 55

TABLE 18 GLOBAL NEW-BORN SCREENING MARKET FOR HOSPITALS BY REGION, 2020-2027 (USD MILLION) 55

TABLE 19 GLOBAL NEW-BORN SCREENING MARKET FOR MATERNITY AND SPECIALTY CLINICS BY REGION, 2020-2027 (USD MILLION) 56

TABLE 20 GLOBAL NEW-BORN SCREENING MARKET FOR DIAGNOSTIC CENTERS BY REGION, 2020-2027 (USD MILLION) 56

TABLE 21 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 59

TABLE 22 AMERICAS: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 59

TABLE 23 AMERICAS: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 60

TABLE 24 AMERICAS: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 25 AMERICAS: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 60

TABLE 26 AMERICAS: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 61

TABLE 27 AMERICAS: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 61

TABLE 28 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 62

TABLE 29 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 62

TABLE 30 NORTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 31 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 63

TABLE 32 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 63

TABLE 33 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 63

TABLE 34 U.S.: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 64

TABLE 35 U.S.: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 36 U.S.: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 64

TABLE 37 U.S.: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 65

TABLE 38 U.S.: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 65

TABLE 39 CANADA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 66

TABLE 40 CANADA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 41 CANADA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 66

TABLE 42 CANADA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 67

TABLE 43 CANADA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 67

TABLE 44 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 68

TABLE 45 SOUTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 46 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 68

TABLE 47 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 69

TABLE 48 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 69

TABLE 49 EUROPE: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 70

TABLE 50 EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 70

TABLE 51 EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 71

TABLE 52 EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 71

TABLE 53 EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 71

TABLE 54 EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 72

TABLE 55 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 72

TABLE 56 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION 72

TABLE 57 WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 58 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 73

TABLE 59 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 73

TABLE 60 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 74

TABLE 61 GERMANY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 74

TABLE 62 GERMANY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 74

TABLE 63 GERMANY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 75

TABLE 64 GERMANY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 75

TABLE 65 GERMANY: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 75

TABLE 66 FRANCE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 76

TABLE 67 FRANCE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 76

TABLE 68 FRANCE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 76

TABLE 69 FRANCE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 77

TABLE 70 FRANCE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 77

TABLE 71 UK: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 78

TABLE 72 UK: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 73 UK: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 78

TABLE 74 UK: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 79

TABLE 75 UK: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 79

TABLE 76 ITALY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 80

TABLE 77 ITALY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 78 ITALY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 80

TABLE 79 ITALY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 81

TABLE 80 ITALY: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 81

TABLE 81 SPAIN: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 82

TABLE 82 SPAIN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 83 SPAIN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 82

TABLE 84 SPAIN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 83

TABLE 85 SPAIN: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 83

TABLE 86 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 84

TABLE 87 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 88 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 84

TABLE 89 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 85

TABLE 90 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 85

TABLE 91 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 86

TABLE 92 EASTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 93 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 86

TABLE 94 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 87

TABLE 95 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 87

TABLE 96 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 88

TABLE 97 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 89

TABLE 98 ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 89

TABLE 99 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 89

TABLE 100 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 90

TABLE 101 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 90

TABLE 102 JAPAN: NEW-BORN SCREENING MARKET, BY PRODUCTS, 2020-2027 (USD MILLION) 91

TABLE 103 JAPAN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 91

TABLE 104 JAPAN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 91

TABLE 105 JAPAN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 92

TABLE 106 JAPAN: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 92

TABLE 107 CHINA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 93

TABLE 108 CHINA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 93

TABLE 109 CHINA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 93

TABLE 110 CHINA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 94

TABLE 111 CHINA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 94

TABLE 112 INDIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 95

TABLE 113 INDIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 114 INDIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 95

TABLE 115 INDIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 96

TABLE 116 INDIA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 96

TABLE 117 AUSTRALIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 97

TABLE 118 AUSTRALIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 97

TABLE 119 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 97

TABLE 120 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 98

TABLE 121 AUSTRALIA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 98

TABLE 122 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 99

TABLE 123 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 99

TABLE 124 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 99

TABLE 125 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 100

TABLE 126 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 100

TABLE 127 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 101

TABLE 128 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 101

TABLE 129 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 101

TABLE 130 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 102

TABLE 131 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 102

TABLE 132 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 103

TABLE 133 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 103

TABLE 134 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 104

TABLE 135 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 104

TABLE 136 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 104

TABLE 137 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 105

TABLE 138 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 105

TABLE 139 MIDDLE EAST: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 105

TABLE 140 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 106

TABLE 141 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 106

TABLE 142 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 106

TABLE 143 AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 107

TABLE 144 AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 145 AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 107

TABLE 146 AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 108

TABLE 147 AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 108

16 List of Figures

FIGURE 1 GLOBAL NEW-BORN SCREENING MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS 23

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NEW-BORN SCREENING MARKET 28

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NEW-BORN SCREENING MARKET 33

FIGURE 6 SUPPLY CHAIN: GLOBAL NEW-BORN SCREENING MARKET 35

FIGURE 7 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY PRODUCT, 2020 (%) 37

FIGURE 8 GLOBAL NEW-BORN SCREENING MARKET, BY PRODUCT, 2020 & 2027 37

FIGURE 9 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 42

FIGURE 10 GLOBAL NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020 & 2027 42

FIGURE 11 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TEST TYPE, 2020 (%) 49

FIGURE 12 GLOBAL NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020 & 2027 49

FIGURE 13 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY END-USER, 2020 (%) 54

FIGURE 14 GLOBAL NEW-BORN SCREENING MARKET, BY END-USER, 2020 & 2027 54

FIGURE 15 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2020 & 2027 (USD MILLION) 58

FIGURE 16 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 58

FIGURE 17 AMERICAS: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 59

FIGURE 18 EUROPE: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 70

FIGURE 19 ASIA-PACIFIC: NEW-BORN SCREENING MARKET SHARE, BY COUNTRY, 2020 (%) 88

FIGURE 20 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 103

FIGURE 21 GLOBAL NEWBORN SCREENING MARKET, MARKET SHARE ANALYSIS 2020 (%) 110

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.